Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion channels to treat age-related neurodegeneration, today announced that its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback